Literature DB >> 8727603

Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.

Y Kasai1, S Takeda, H Takagi.   

Abstract

Chronic liver inflammation and hepatic regeneration by infection with hepatitis B (HBV) or C virus (HBC) seem to be important risk factors for hepatocellular carcinoma (HCC). Regarding the hepatocarcinogenesis of HBV DNA integration, it has been variously hypothesized that mechanisms such as the alteration of host chromosomal DNA and transcriptional trans-acting activity of the X gene are activated. On the other hand, integration of HCV virus into chromosomal DNA has not been reported. It is suggested that HCV could replicate more efficiently in noncancerous than in cancerous tissues. Therefore, it might affect some oncogenes or cause an inactivation of tumor suppressor genes in the early stage of HCC. Genetic alterations such as a point mutation and loss of heterozygosity are considered to be late events occurring after tumorigenesis. Regeneration of liver cells through chronic hepatitis increases the incidence of genetic alterations in hepatic cells and/or HCCs in both HBV- and HCV-infected patients.

Entities:  

Mesh:

Year:  1996        PMID: 8727603     DOI: 10.1002/(SICI)1098-2388(199605/06)12:3<155::AID-SSU2>3.0.CO;2-6

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  9 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Molecular genetics of hepatocellular neoplasia.

Authors:  Shilpa Jain; Shashideep Singhal; Peng Lee; Ruliang Xu
Journal:  Am J Transl Res       Date:  2010-01-23       Impact factor: 4.060

3.  Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma.

Authors:  Chun Feng Lee; Zhi Qiang Ling; Ting Zhao; Shih Hua Fang; Weng Cheng Chang; San Chih Lee; Kuan Rong Lee
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

4.  Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.

Authors:  Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader; Mohamed Hassan
Journal:  World J Hepatol       Date:  2012-12-27

5.  Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma.

Authors:  Chun-Feng Lee; Zhi-Qiang Ling; Ting Zhao; Kuan-Rong Lee
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

6.  Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice.

Authors:  Dhwanil A Dalwadi; Laura Torrens; Jordi Abril-Fornaguera; Roser Pinyol; Catherine Willoughby; Jeffrey Posey; Josep M Llovet; Christian Lanciault; David W Russell; Markus Grompe; Willscott E Naugler
Journal:  Mol Ther       Date:  2020-10-22       Impact factor: 11.454

7.  Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization.

Authors:  C Sakakura; A Hagiwara; H Taniguchi; T Yamaguchi; H Yamagishi; T Takahashi; K Koyama; Y Nakamura; T Abe; J Inazawa
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

8.  Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma.

Authors:  Chia-Jui Yen; Yih-Jyh Lin; Chia-Sheng Yen; Hung-Wen Tsai; Ting-Fen Tsai; Kwang-Yu Chang; Wei-Chien Huang; Pin-Wen Lin; Chi-Wu Chiang; Ting-Tsung Chang
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

9.  Prevalence of hepatitis B and C in patients with meningiomas and glioblastoma multiforme.

Authors:  Marc B Cabanne; Quang D Ma; Lillian Mecum; Rahul Jandial; Javed Siddiqi; Mike Y Chen
Journal:  Oncol Lett       Date:  2013-01-10       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.